CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Eagle Pharmaceuticals, Inc. v. Baxter Healthcare Corporation

1:24-cv-00066

Overview

Case Number 1:24-cv-00066
Filing Date 2024-01-17
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Baxter Healthcare Corporation NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Eagle Pharmaceuticals, Inc. Operating Company

Represented By

3 Attorneys Listed

Maliheh Zare

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

405 N. King Street, Wilmington, DE 19801

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11844783
Formulations of bendamustine
Filed: 2022-12-14
Issued: 2023-12-19
Active (16.1 yrs remaining)
Expires: 2042-12-14
US11872214
Formulations of Bendamustine
Filed: 2022-12-14
Issued: 2024-01-16
Active (16.1 yrs remaining)
Expires: 2042-12-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

61

Dispositive

0

Granted

2

Denied

0

Pending / Review

48

Motions by Category

Procedural / Extension Motion 37 Claim Construction / Markman Filing 24

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #278 • 2026-04-21 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #276 • 2026-04-14 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (275 in 1:24-cv-00066-JLH, 323 in 1:24-cv-00064-JLH, 318 in 1:24-cv-00065-JLH) Stipulation and Order to Extend Time for Service of Defendants' Re...
Entry #β€” • 2026-04-14
Procedural / Extension Motion Pending / Under Review
STIPULATION to Extend Time for Service of Defendants' Reply Expert Report of David E. Bugay - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth)
Entry #275 • 2026-04-13 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #272 • 2026-04-07 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #264 • 2026-03-19 Document →

Docket Entries

(361 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Baxter Healthcare Corporation ( Filing fee $ 405, receipt number ADEDC-4316835.) - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet) (vfm) (Entered: 01/18/2024)

Entry #1 • 2024-01-17
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 01/18/2024)

Entry #2 • 2024-01-17
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,844,783; 11,872,214. (vfm) (Entered: 01/18/2024)

Entry #3 • 2024-01-17
1

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc.. (vfm) (Entered: 01/18/2024)

Entry #4 • 2024-01-17
1

Summons Issued as to Baxter Healthcare Corporation on 1/17/2024. (vfm) (Entered: 01/18/2024)

Entry #5 • 2024-01-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc